Learning from the 2001 anthrax attacks: immunological characteristics.
Hadler
James L
JL
D000881:Anthrax / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology / Q000503:physiopathology; D022122:Anthrax Vaccines / Q000008:administration & dosage / Q000276:immunology; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood*; D001408:Bacillus anthracis / Q000472:pathogenicity* / Q000502:physiology; D023482:Bioterrorism; D006801:Humans; D007111:Immunity, Cellular; D019570:Inhalation Exposure; D013171:Spores, Bacterial / Q000472:pathogenicity; D014611:Vaccination
D022122:Anthrax Vaccines; D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial